先天性氯化物腹泻的临床特征、分子遗传学及长期结局:日本全国性研究
该研究对日本616家儿科中心2014至2018年确诊的先天性氯化物腹泻(CCD)患儿进行多机构回顾性调查,13例符合全部入组标准并检出SLC26A3突变。最常见突变为c.2063-1g>t(7/13),中位诊断年龄1天,中位随访10年,多数患儿排便次数随年龄减少,神经发育总体良好,部分需长期电解质补充。
要点
- 13例符合全部入组标准并检出SLC26A3突变,其中6种为新突变。
- c.2063-1g>t最常见(7/13),可能是东亚奠基者突变。
- 中位诊断年龄1天,69%在新生儿期确诊,中位随访10年。
核心结论
- 胎儿超声早期诊断和及时长期钠、钾、氯补充是常见管理特征。
- SLC26A3基因分析可提供CCD的明确诊断。
- c.2063-1g>t可能是东亚奠基者突变,与既往报道地区不同。
研究设计与样本
- 多机构回顾性调查,覆盖日本616家儿科中心。
- 纳入2014至2018年确诊的CCD患儿。
- 通过Sanger测序检测SLC26A3突变。
主要发现
- 13例符合全部入组标准并检出SLC26A3突变,14例满足临床诊断标准。
- 13/14例(93%)检出SLC26A3纯合或复合杂合突变,含6种新突变。
- 最常见突变为c.2063-1g>t,见于7/13例。
- 中位诊断年龄1天,9/13例(69%)在新生儿期诊断,中位随访10年。
- 随访时8例(62%)每日排便<5次且均少于婴儿期;1例肾钙质沉着,3例(23%)轻度慢性肾脏病;仅1例需特殊教育;5例(38%)长期补充钠、钾、氯。
关键数值与推荐
- 13例符合全部入组标准并检出SLC26A3突变,14例满足临床诊断标准。
- SLC26A3突变检出率为93%(13/14)。
- c.2063-1g>t检出率为7/13。
- 新生儿期诊断比例为69%(9/13)。
- 随访时每日排便<5次者为62%(8/13),轻度慢性肾脏病者为23%(3/13),长期电解质补充者为38%(5/13)。
临床怎么用
- 对疑似CCD患儿应尽早行SLC26A3基因分析以明确诊断。
- 新生儿期即可通过临床表现和基因检测确诊CCD。
- 长期管理需关注钠、钾、氯补充及肾功能监测。
- 多数患儿排便次数随年龄改善,神经发育结局总体良好。
局限性
- 回顾性研究设计。
- 样本量较小(13例符合全部标准)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify clinical and genetic features of Japanese children with congenital chloride diarrhea (CCD). STUDY DESIGN: This was a multi-institutional, retrospective survey of 616 pediatric centers in Japan with identified patients with CCD between 2014 and 2018. Mutations involving SLC26A3 were detected by Sanger sequencing. RESULTS: Thirteen patients met all entry criteria including mutations in SLC26A3, and 14 patients satisfied clinical diagnostic criteria. Homozygous or compound heterozygous mutations in SLC26A3, including 6 novel mutations, were identified in 13 of these 14 patients (93%). The most common (detected in 7 of 13) was c.2063-1g>t. Median age at diagnosis was 1 day. Nine of the patients meeting all criteria were diagnosed as neonates (69%). Median follow-up duration was 10 years. When studied, 8 patients had <5 stools daily (62%), and all had fewer than in infancy. Only 1 patient had nephrocalcinosis, and 3 (23%) had mild chronic kidney disease. Neurodevelopment was generally good; only 1 patient required special education. Five patients (38%) received long-term sodium, potassium, and chloride supplementation. CONCLUSIONS: Early fetal ultrasound diagnosis and prompt long-term sodium, potassium, and chloride supplementation were common management features. Genetic analysis of SLC26A3 provided definitive diagnosis of CCD. In contrast with previously reported localities, c.2063-1g>t might be a founder mutation in East Asia.
引用
- Konishi KI, Mizuochi T, Yanagi T, et al. Clinical Features, Molecular Genetics, and Long-Term Outcome in Congenital Chloride Diarrhea: A Nationwide Study in Japan. J Pediatr. 2019. PMID: 31477378. doi:10.1016/j.jpeds.2019.07.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。